Financials
Value Q4, 24Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM Selling/general/admin expenses 10 M9 M10 M10 M11 M11 M 42 M Research & development —————— — Operating income 2.03 B-1.13 B-412 M-16 M471 M741 M 784 M Non-Operating Income, Total 39 M-81 M-274 M688 M789 M-433 M 770 M Interest expense, net of interest capitalized 741 M687 M668 M755 M738 M731 M 2.89 B Non-Operating Income, excl. Interest Expenses 39 M-81 M-274 M688 M789 M-433 M 770 M Unusual income/expense —————— — Pretax income 2.07 B-1.21 B-686 M672 M1.26 B308 M 1.55 B Equity in earnings —————— — Taxes —————— — Non-controlling/minority interest —————— — After tax other income/expense —————— — Net income before discontinued operations 122 M50 M-140 M806 M954 M-148 M 1.47 B Discontinued operations —————— — Net income 122 M50 M-140 M806 M954 M-148 M 1.47 B Dilution adjustment 000000 0 Preferred dividends 36 M35 M38 M42 M46 M44 M 170 M Diluted net income available to common stockholders 86 M15 M-178 M764 M908 M-192 M 1.3 B Basic earnings per share (Basic EPS) 0.060.02-0.170.730.9-0.17 1.29 Diluted earnings per share (Diluted EPS) 0.060.02-0.170.720.9-0.17 1.28 Average basic shares outstanding 783.4 M918.3 M1.02 B1.05 B1.02 B1.12 B — Diluted shares outstanding 786 M921.9 M1.02 B1.06 B1.02 B1.12 B — EBITDA 1.26 B739 M-1.05 B-714 M-216 M62 M -1.92 B EBIT 1.29 B-1.81 B-1.08 B-771 M-267 M10 M -2.11 B Cost of revenue —————— — Other cost of goods sold —————— — Depreciation & amortization (cash flow) -11 M39 M30 M57 M51 M52 M 190 M